AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability.
Glutamate-activated α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPA-Rs) mediate the majority of excitatory neurotransmission in brain and thus are major drug targets for diseases associated with hyperexcitability or neurotoxicity. Due to the critical nature of AMPA-Rs in normal...
Saved in:
| Main Authors: | Nicole M Lykens, David J Coughlin, Jyoti M Reddi, Gordon J Lutz, Melanie K Tallent |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171538&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cysteine 893 is a target of regulatory thiol modifications of GluA1 AMPA receptors.
by: Lotta von Ossowski, et al.
Published: (2017-01-01) -
Endophilin2 Interacts with GluA1 to Mediate AMPA Receptor Endocytosis Induced by Oligomeric Amyloid-β
by: Jifeng Zhang, et al.
Published: (2017-01-01) -
Elevated Autoantibodies to the GluA1 Subunit of the AMPA Receptor in Blood Indicate Risk of Cognitive Impairment in Contact Sports Athletes, Irrespective of Concussion
by: Christopher Bailey, et al.
Published: (2024-11-01) -
GluA1 Phosphorylation Alters Evoked Firing Pattern In Vivo
by: Balázs Barkóczi, et al.
Published: (2012-01-01) -
Identification of a novel signaling pathway and its relevance for GluA1 recycling.
by: Guiscard Seebohm, et al.
Published: (2012-01-01)